Tianshui Zhongxing Bio-technology Co Ltd (002772)

Currency in CNY
8.20
+0.05(+0.61%)
Closed·

002772 Financial Summary

Key Ratios

P/E Ratio21.59
Price/Book0.88
Debt / Equity76.32%
Return on Equity4.11%
Dividend Yield3.66%
EBITDA414.22M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2023
01/01
2023
31/12
2024
31/12
* In Millions of CNY (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.37%
Dividend Yield
3.66%
Industry Median 2.34%
Annualised payout
0.30
Paid annually
5-Years Growth
+24.57%
Growth Streak

Earnings

Latest Release
Apr 18, 2025
EPS / Forecast
0.13 / --
Revenue / Forecast
472.64M / --
EPS Revisions
Last 90 days

FAQ

What were Tianshui Zhongxing Bio-tech's earnings for the latest quarter?

The Tianshui Zhongxing Bio-tech EPS (TTM) is 0.37. Tianshui Zhongxing Bio-tech reported sales of 472.64, net income of 48.20, and EPS of 0.13 for the latest quarter.

What was Tianshui Zhongxing Bio-tech's net income for the latest quarter?

Tianshui Zhongxing Bio-tech's net income for the latest quarter was 48.20.

How did Tianshui Zhongxing Bio-tech's performance compare year-over-year in the latest quarter?

The company's revenue moved from 518.75 in the previous quarter to 472.64 in the latest quarter, and net income moved from 39.38 to 48.20 compared to the previous quarter.

What is Tianshui Zhongxing Bio-tech's net profit margin on a TTM basis?

Tianshui Zhongxing Bio-tech's trailing twelve months (TTM) net profit margin is 6.62%.

How does Tianshui Zhongxing Bio-tech's debt to equity ratio compare to industry standards?

Tianshui Zhongxing Bio-tech's total debt-to-equity ratio is 76.32%.

What is Tianshui Zhongxing Bio-tech's return on investment on a TTM basis?

Tianshui Zhongxing Bio-tech's trailing twelve months (TTM) return on investment (ROI) is 4.11%.

Did Tianshui Zhongxing Bio-tech gain or lose cash last quarter?

In the latest quarter, Tianshui Zhongxing Bio-tech's net change in cash was 193.47 million.

What were Tianshui Zhongxing Bio-tech's total assets and liabilities in the latest quarter?

As of the latest quarter, Tianshui Zhongxing Bio-tech reported total assets of 6,386.59 million and total liabilities of 1,469.15 million.

How has Tianshui Zhongxing Bio-tech's total revenue grown this year?

Tianshui Zhongxing Bio-tech's total revenue was 518.75 in the previous quarter and 472.64 in the latest quarter.

What is Tianshui Zhongxing Bio-tech's gross margin on a TTM basis?

Tianshui Zhongxing Bio-tech's trailing twelve months (TTM) gross margin is 20.94%.

What was Tianshui Zhongxing Bio-tech's revenue per share for the latest quarter?

Tianshui Zhongxing Bio-tech's revenue per share for the latest quarter was 9.42.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.